Difficulty: Medium
Average Score: 87%
Practice
Chronic use of which of the following may increase paracetamol toxicity
Correct answer
C
Rationale
In the context of pharmacology, this question addresses the potential interaction between drugs and their impact on the toxicity of paracetamol (acetaminophen). The correct answer is C) Rifampicin.
Rifampicin is an enzyme inducer that can increase the metabolism of paracetamol in the liver through the cytochrome P450 system. This increased metabolism can lead to the production of a toxic metabolite of paracetamol, N-acetyl-p-benzoquinone imine (NAPQI), which can cause liver damage and toxicity when accumulated in excessive amounts.
A) Cimetidine is a cytochrome P450 inhibitor, which would actually decrease the metabolism of paracetamol and potentially reduce its toxicity.
B) Ketoconazole is also a cytochrome P450 inhibitor and would not increase paracetamol toxicity.
D) "None of the above" is incorrect as rifampicin does indeed have the potential to increase paracetamol toxicity through enzyme induction.
Understanding these drug interactions is crucial in clinical practice to prevent adverse drug reactions and ensure patient safety. Pharmacology education emphasizes the importance of recognizing how different drugs can interact and impact each other's effects in the body, highlighting the significance of considering these interactions in clinical decision-making.
Rifampicin is an enzyme inducer that can increase the metabolism of paracetamol in the liver through the cytochrome P450 system. This increased metabolism can lead to the production of a toxic metabolite of paracetamol, N-acetyl-p-benzoquinone imine (NAPQI), which can cause liver damage and toxicity when accumulated in excessive amounts.
A) Cimetidine is a cytochrome P450 inhibitor, which would actually decrease the metabolism of paracetamol and potentially reduce its toxicity.
B) Ketoconazole is also a cytochrome P450 inhibitor and would not increase paracetamol toxicity.
D) "None of the above" is incorrect as rifampicin does indeed have the potential to increase paracetamol toxicity through enzyme induction.
Understanding these drug interactions is crucial in clinical practice to prevent adverse drug reactions and ensure patient safety. Pharmacology education emphasizes the importance of recognizing how different drugs can interact and impact each other's effects in the body, highlighting the significance of considering these interactions in clinical decision-making.